logo-loader
viewG Medical Innovations Holdings Ltd

G Medical Innovations in trading halt ahead of Nasdaq listing

The company’s securities will be placed in trading halt until Monday August 26 or when an announcement is made to market.

G Medical Innovations Holdings Ltd - G Medical Innovations Ltd in trading halt ahead of Nasdaq listing
US revenues have increased by 200% year-on-year

G Medical Innovations Ltd (ASX:GMV) is in trading halt pending an announcement regarding its Nasdaq listing.

The trading halt will remain in place until the beginning of trade on Monday August 26 or when an announcement is made to market – whichever occurs earliest.

UK operations

The company established its UK headquarters last quarter and completed the pilot programs for its CE approved health monitoring solution, Patch.

The UK market for G Medical comprises the national healthcare system (NHS), private hospital groups, nursing and aged care facilities as well as other market participants.

UK’s healthcare system is compatible with G Medical’s business model and services and is an important territory for deployment, given both the Prizma and the Patch are regulatory approved for use within the UK.

US operations

G Medical Diagnostic Services Inc’s (GMEDx) Independent Testing Facility (IDTF) operations have seen consistent month on month new patient enrolment in the US.

As part of GMEDx’ growth strategy, the division will increase its sales force to provide for continued increase in patient enrolments within the market, as well as to push Prizma from POC to full commercialisation.

Quick facts: G Medical Innovations Holdings Ltd

Price: 0.1 AUD

ASX:GMV
Market: ASX
Market Cap: $40.89 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 16/10/18

2 min read